This Review covers the rationale, physiological consequences and clinical application of
pharmacological sodium–glucose cotransporter 2 (SGLT2) inhibition. In patients with type 2 …

OBJECTIVE Cotadutide, a dual GLP-1 and glucagon receptor agonist, is under development
for nonalcoholic steatohepatitis (NASH) and chronic kidney disease with type 2 diabetes …

Objective Postprandial hyperinsulinemic hypoglycemia with neuroglycopenia is an
increasingly recognized complication of Roux‐en‐Y gastric bypass and gastric sleeve …

Background Weight loss is often key in the management of obese or overweight patients
with type 2 diabetes, yet few treatments for diabetes achieve clinically meaningful weight …

Abstract Aims The second Diabetes Attitudes, Wishes and Needs (DAWN 2) study aimed to
assess psychosocial outcomes in people with diabetes across countries for benchmarking …

OBJECTIVE To investigate the efficacy and tolerability of empagliflozin as an add-on to
metformin therapy in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS …

Our objective was to establish a diabetes mellitus type 2 (DM2) model in rats using a high-fat
diet and streptozotocin (HF-STZ). Male Wistar rats (240-250g) were divided into a control …

Infusion of mesenchymal stem cells (MSCs) has been shown to effectively lower blood
glucose in diabetic individuals, but the mechanism involved could not be adequately …

Aim To investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of
empagliflozin in patients with type 2 diabetes following oral administration of 10, 25 or 100 …

Background Diabetes is a major public health concern. In spite of continuous new drug
development to treat diabetes, herbal remedies remain a potential adjunct therapy to …